Postprandial Glucose Control Using the Medtronic Advanced Hybrid Closed-Loop System: Faster-Acting Insulin Aspart vs. Insulin Aspart

被引：1
|
作者：
Lee, Melissa H.
Vogrin, Sara
Paldus, Barbora
Morrison, Dale
Zaharieva, Dessi
Lu, Jean
Jones, Hannah
Wyatt, Sue A.
Netzer, Emma
Sims, Catriona M.
Macisaac, Richard
Grosman, Benyamin
Roy, Anirban
Kurtz, Natalie
Jenkins, Alicia
Oneal, David N.
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-234-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
234-OR
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Fast-Acting Insulin Aspart Versus Insulin Aspart Using a Second-Generation Hybrid Closed-Loop System in Adults With Type 1 Diabetes: A Randomized, Open-Label, Crossover Trial
    Lee, Melissa H.
    Paldus, Barbora
    Vogrin, Sara
    Morrison, Dale
    Zaharieva, Dessi P.
    Lu, Jean
    Jones, Hannah M.
    Netzer, Emma
    Robinson, Lesley
    Grosman, Benyamin
    Roy, Anirban
    Kurtz, Natalie
    Ward, Glenn M.
    MacIsaac, Richard J.
    Jenkins, Alicia J.
    O'Neal, David N.
    DIABETES CARE, 2021, 44 (10) : 2371 - 2378
  • [42] Faster-Acting Insulin Aspart Using Continuous Subcutaneous Insulin Infusion (CSII): Earlier Onset of Exposure and Greater Early Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects than Insulin Aspart
    Heise, Tim
    Zijlstra, Eric
    Rikte, Tord
    Thorsson, Lars
    Nosek, Leszek
    Haahr, Hanne
    DIABETES, 2015, 64 : A256 - A256
  • [43] A Comparison of Postprandial Glucose Control in the Medtronic Advanced Hybrid Closed-Loop System Versus 670G
    Weinzimer, Stuart A.
    Bailey, Ryan J.
    Bergenstal, Richard M.
    Nimri, Revital
    Beck, Roy W.
    Schatz, Desmond
    Ambler-Osborn, Louise
    Schweiger, Darja Smigoc
    von dem Berge, Thekla
    Sibayan, Judy
    Johnson, Mary L.
    Calhoun, Peter
    Phillip, Moshe
    Criego, Amy
    Carlson, Anders
    Martens, Thomas
    Beasley, Shannon
    Whipple, Diane
    Hyatt, Jamie
    Punel, Alina
    Grieme, Aimee
    Thomas, Lee Ann
    LaFrance, Amy
    Hasledalen, Caitlin
    Laffel, Lori
    Isganaitis, Elvira
    Freiner, Emily
    Desrochers, Hannah
    Turcotte, Christine
    Naik, Nisha
    Roethke, Lindsay
    Fisher, Margaret
    Nevo, Michal
    Bello, Rachel
    Hamou, Alona
    Hermon, Orna
    Horesh, Orit
    Mantzuri, Galit Shiovitch
    Drotz, Irit
    Yehiel, Nava
    Naveh, Rachel
    Haller, Michael
    Albanese-O'Neill, Anastasia
    Sheehan, Eleni
    Sheehan, Eleni
    Smith, Madison
    Jacobsen, Laura
    Adams, Janey
    Hosford, Jennifer
    Whyte, Loren
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (08) : 573 - 582
  • [44] HYBRID CLOSED-LOOP WITH FASTER INSULIN ASPART COMPARED WITH STANDARD INSULIN ASPART IN VERY YOUNG CHILDREN WITH TYPE 1 DIABETES: A DOUBLE-BLIND, MULTICENTRE, RANDOMISED, CROSSOVER STUDY
    Ware, J.
    Allen, J.
    Boughton, C.
    Cezar, A.
    Hartnell, S.
    Wilinska, M.
    Thankamony, A.
    Deakin, M.
    Leyland, H.
    Phelan, K.
    Thornborough, K.
    Hovorka, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A56 - A56
  • [45] Hybrid Closed-Loop with Faster Insulin Aspart Compared with Standard Insulin Aspart in Very Young Children with Type 1 Diabetes: A Double-Blind, Multicenter, Randomized, Crossover Study
    Ware, Julia
    Allen, Janet M.
    Boughton, Charlotte K.
    Cezar, Alina
    Hartnell, Sara
    Wilinska, Malgorzata E.
    Thankamony, Ajay
    Deakin, Mark
    Leyland, Hannah
    Phelan, Karen
    Thornborough, Keith
    Hovorka, Roman
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (06) : 431 - 436
  • [46] HIGHER EARLY EXPOSURE AND GREATER EARLY GLUCOSE-LOWERING EFFECT WITH FASTER-ACTING INSULIN ASPART VS INSULIN ASPART IN ELDERLY AND YOUNGER ADULTS WITH TYPE 1 DIABETES (T1D)
    Hoevelmann, U.
    Zijlstra, E.
    Stender-Petersen, K.
    Jacobsen, J. B.
    Heise, T.
    Haahr, H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A44 - A45
  • [47] Day-to-day consistency was observed in the greater early glucose-lowering effect of faster-acting insulin aspart
    Nosek, Leszek
    Haahr, Hanne
    Heise, Tim
    Hoevelmann, Ulrike
    Erichsen, Lars
    Zijlstra, Eric
    Stender-Petersen, Kirstine
    CLINICAL ENDOCRINOLOGY, 2017, 86 : 45 - 46
  • [48] Improved Glycemic Control with Carbohydrate Counting for Adjustment of Fast-Acting Insulin Aspart vs. Insulin Aspart in Subjects with Type 1 Diabetes
    Philis-Tsimikas, Athena
    Bode, Bruce W.
    Franek, Edward
    Rose, Ludger
    Buchholtz, Kristine
    Demissie, Marek
    Pieber, Thomas R.
    DIABETES, 2017, 66 : A260 - A260
  • [49] REDUCTION OF HYPOGLYCAEMIA USING HYBRID CLOSED-LOOP WITH FASTER-INSULIN ASPART COMPARED WITH STANDARD-INSULIN ASPART IN ADULTS WITH TYPE 1 DIABETES: A DOUBLE-BLIND, MULTINATIONAL, RANDOMISED, CROSSOVER STUDY
    Boughton, C.
    Hartnell, S.
    Thabit, H.
    Poettler, T.
    Herzig, D.
    Wilinska, M.
    Ashcroft, N.
    Sibayan, J.
    Cohen, N.
    Calhoun, P.
    Bally, L.
    Mader, J.
    Evans, M.
    Leelarathna, L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A72 - A73
  • [50] Faster-acting insulin aspart: faster offset of exposure and action in addition to faster onset in subjects with type 1 diabetes using continuous subcutaneous insulin infusion
    Zijlstra, E.
    Heise, T.
    Nosek, L.
    Rikte, T.
    Haahr, H.
    DIABETOLOGIA, 2016, 59 : S98 - S99
12345